Abstract Higher indoor concentrations of air pollutants d ue,in part, to lower ventilation rates are a potential cause of sick building syn drome (SBS) symptoms in office workers. The indoor carbon dioxide (C02) concentration is an approximate surrogate for indoor concen trations of other occupant-generated pollutants and for ventilation rate per occupant. Using multivariate logistic regression (MLR) analyses, we evaluated the relationship between indoor C02 con centrations and SBS symptoms in occupants from a probability sample of 41 U.S. office buildings. Two C02 metrics were con structed: average workday indoor minus average outdoor C02 (dC02, range 6-418 ppm), and maximum indoor 1-h moving aver age C02 minus outdoor C02 concentrations (dC02MAX). MLR analyses quantified dC02/SBS symptom associations, adjusting for personal and environmental factors. A dose-response relationship (p<0.05) with odds ratios per 100 ppm dC02 ranging from 1.2to 1.5 for sore throat, nose/ sinus, tight chest, and wheezing was observed. The dC02MAX/SBS regression results were similar.
Introduction
Building Ventilation and Indoor C02
Concentrations
The primary indoor source of C02 in office buildings is the respiratio � of the building occupants:_ C02 concentrations in office buildings typically range from 350 to 2500 ppm (Seppanen et al., 1999) . At the concen trations occurring in most indoor environments, C02 buildup is thought to be a surrogate for other occu pant-generated pollutants, particularly bioeffluents, and ventilation rate per occupant, but not a causal fac tor in human health responses. The Threshold Limit Value for 8-h time-weighted-average exposures to C02 is 5,000 ppm (ACGIH, 1991) .
Outdoor air contains approximately 350 ppm of C02. The release of C02 by occupants causes indoor C02 concentrations to exceed outdoor concentrations by an amount that depends on the rate of outside air supply per occupant and the time elapsed since the occupants entered the building. Concentrations of other indoor-generated contaminants should be rough ly correlated with the difference between the indoor C02 concentration and the concentration in the out door air supplied to the building. The correlation should be strongest for other human bioeffluents and weaker for pollutants emitted by building materials, furniture, electronic and office equipment, cleaning and other activities (Bluyssen et al., 1996; Seppanen et al., 1999) .
The lowest minimum ventilation rate guideline set by the American Society of Heating, Refrigeration, and Air Conditioning Engineers (ASHRAE) in Standard ASHRAE 62-1999 is 8 Ls-1 per person (ASHRAE, 1999) . Based upon mass-balance calculations, this corresponds to a maximum acceptable steady state in door C02 concentration of 1,000 ppm, assuming an outdoor C02 concentration of 350 ppm and a C02 gen eration rate per person of 0.31 Lmin-L For offices, the recommended minimum ventilation rate is 10 Ls-1 per person which, using the above assumptions, corre--t Deceased, Indoor Environment Depart111e11t, Lawre11ce Berkeley National Laboratory, 1 Cyclotron Rd., Berkeley CA 94720, USA, Fax:+l 510 486 6658� e-mail: MGApte@lbl.gov, •Author !o whom correspo11de11ce should be add_ressed.
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sponds to a steady-state indoor concentration of ap proximately 870 ppm. Because C02 concentrations in offices usually do not equilibrate, measured concen trations are not easily translated into ventilation rates.
Sick Building Syndrome Symptoms
SBS is used to describe a set of adverse health or dis comfort symptoms that individuals experience when they spend time indoors, particularly in office build ings, and that lessen while away from the building. SBS symptoms do not indicate either a particular ex posure or a specific disease (Levin, 1989; Mendell, 1993) . The prevalence of workers experiencing symp toms typically ranges from a few percent to 50 -60% depending upon the symptom and the environment. SBS symptoms are often classified by the affected re gion and system of the body. The classifications are as follows: upper respiratory and mucosal symptoms, typically reported as dry, itchy, sore, burning, or other wise irritated eyes, nose, sinus, or throat; lower respir atory irritation or distress such as cough, tight chest, wheeze, or difficulty breathing; neuro-physiological symptoms including headache, drowsiness, lethargy, tiredness, mental fatigue, dizziness, etc.; and skin irri tation symptoms such as itching or stinging, dryness, or reddening (Levin, 1989) .
C02 and SBS Studies in the Literature
A thorough review of the literature regarding building ventilation and C02 buildup, and their association with health, comfort, and productivity was recently compiled by Seppanen et al. (1999,) . Their review summarizes the results of 22 studies of SBS symptoms in office buildings where C02 measurements were made over 30,000 sub jects in more than 400 buildings in North America, Eur ope, and Asia. About one-half of the studies found a statistically significant (p:50.05) positive association be tween C02 levels and one or more SBS symptoms. In these studies, indoor C02 concentrations were associ ated with headache, fatigue, eye symptoms, nasal symp toms, respiratory tract symptoms, and total symptom scores. The respiratory symptoms included throat and lower respiratory symptoms, and difficulty breathing. When considering studies of mechanically ventilated or air-conditioned buildings but not the naturally venti lated buildings, the proportion of studies showing a statistically significant positive association between C02 and SBS symptoms rose to 70%. These associations for C02 and SBS in office buildings were consistent with _ the observed association b�tween building ventilation _ and SBS symptoms. When the studies are aggregated, there is a statistically significant higher prevalence of SBS symptoms in buildings with ventilatlon rates below 10 Ls-1 compared with buildings with ventilation rates at or above 10 Ls-1. The review also indicated that sev eral studies found that increases in ventilation rates to 20 Ls-1 were associated with significant decreases in SBS symptoms.
In existing studies, null or negative findings of the associations of SBS symptoms with both C02 and ven tilation studies should not necessarily be interpreted as evidence that ventilation is not a determinant factor in predicting SBS. We acknowledge that epidemiological studies are difficult to conduct, however, potential ex planations for the absence of associations in other studies ·include the following: poor statistical power; study designs and analyses that did not adequately ac count for confounding variables; or insufficient ability to characterize C02 concentrations in the buildings and the symptoms of the building occupants. Such prob lems tend to mask the hypothesized effects rather than producing spurious associations, which could explain some of the null findings in the literature.
Assumptions and Hypotheses
In this paper, it is assumed that adequate office build ing ventilation is necessary to remove pollutants gener ated within the building. Indoor pollutant SQurces in clude the occupants themselves, tobacco smoke, the building structure and fixed furnishings, office equip ment, and materials used for cleaning and mainten ance. Building occupants are the dominant source of C02 increases in buildings. Indoor pollutants are re moved by dilution through ventilation with outdoor air. At constant occupancy, changes in indoor C02 con centrations are correlated with changes in the concen trations of other pollutants in the building volume.
We hypothesize that in occupied office buildings, in door minus outdoor C02 concentrations (�C02) are as sociated with occupant SBS symptoms. This is because �C02 is correlated with indoor pollutant exposures that cause these symptoms through chemically or physically mediated stress to the organism.
Methods

The BASE Study
The data analyzed in this paper were collected in 41 large U.S. office buildings from 1994 to 1996, a subset of 100 buildings studied from 1994-1998 by the U.S. Environmental Protection Agency (EPA) in the Build ing Assessment Survey and Evaluation (BASE) study "Y_omble et al., 1995; Wombl� et al., 1996) . These 100 buildings were selected at random to be a representative sample of the nation's office building -stock, however at the time -that the analyses --were conducted, only the 1994-1996 data were avail able. These 41 buildings are located in 14 states (AZ, CA, CO, FL, LA, MN, MO, NE, NY, OR, PA , SC, TN, and TX). All 41 of these buildings were at least par tially mechanically ventilated and utilized air con ditioning in at least a portion of the monitored work spaces. There were a total of 1970 individuals studied in these 41 buildings. Individual BASE buildings were studied during 1-week periods of the winter or summer months. The BASE protocol (see Womble et al., 1993 and USEPA BASE Website reference for more details) includes the assembly of an exhaustive database on the physical characteristics of the buildings' construction and HVAC systems and extensive indoor and outdoor en vironmental monitoring data from a selected space within each building. Data were also solicited via ques tionnaire from all study space occupants within each building, with a median response rate of 87%. The questionnaire collected information on the occupants' perceptions of their workplace environments, job characteristics, and health and well being (including symptoms associated with SBS). The environmental data were collected during the same week that the questionnaire was administered. Real-time environ mental data were collected from Tuesday morning through Thursday evening while integrated samples were collected during the Wednesday workday. The questionnaire was administered during work hours on Thursday. The study date for each building is provided in Appendix l.
'
Description of the BASE Study Measurements
At each office building, eo2, volatile organic com pounds (VOes), temperature, relative humidity (RH), and other potential indoor pollutants were measured at a single outdoor location, and indoors at three loca tions, representing locations of building occupancy, at a vertical height of 1.1 meters. Real-time infrared C02 analyzers collected data that were stored as 5-min av erages for each measurement location. voe samples were collected over 9 h in canisters and analyzed by gas chromatograph-mass spectrometry for 56 voe species. Indoor temperature was measured at four ver tical strata (0.1, 0.6, 1.1, and 1.7 meters) and was col lected along with outdoor data as 5-min averages.
We calculated workday (defined as 8:00-17:00, Tues day-Thursday) spatial-average pollutant concen trations_ and temperatures based on__ data from the three measurement sites. Two C02 exposure metrics were calculated. One metric (dC02) was calculated as follows:
where,
C0 2 indoor = the time-averaged indoor workday e02 concentration, and C02 outdoor=the time average outdoor workday e02 concentration.
The second metric (de02Max) was calculated as:
C0 2 1 h max_ind oor =maximum workday 1 hr moving average C02 concentration, and Indoor voe concentrations were calculated from workday time-weighted-average (TWA) measurements across the three indoor sites. A value of one-half of the limit of detection (LOD) was used to replace values reported as below LOD for individual voe species. Thermal exposure (0e-h) was calculated as the inte grated difference between 5-min-average-temperature and 20°e, averaged over 3 indoor locations and 2 measurement heights (1.1 and 1.7 meters). Associations between selected VOes and SBS symp toms were studied previously (Apte and Daisey,.1999) . In that study, one common aromatic hydrocarbon, 1,2,4 trimethylbenzene (TMB) was found to have statisti cally significant associations with a number of mucous membrane and lower respiratory symptoms. In par ticular, TMB was identified as a component of infiltrat ing outdoor air originating from automotive sources. TMB was selected as a covariate in the regression models presented in order to adjust for the potential affects of ambient automotive sources on the SBS symptoms. The geometric mean (geometric standard deviation) TMB concentration across the 41 buildings was 1.2 (3.0) ppb. Appendix 1 contains the TMB data by BASE building.
The indoor average-workday RH was calculated for each building (Appendix 1). Indoor RH varied from 10% to almost 60%. Although not conclusive, lbw RH conditions are suspected contributors to SBS symp toms. Some studies reported in the literature (Mendell, 1993; Menzies and Bourbeau, 1997) have shown in creased prevalence of mucosa! and skin SBS symptoms in buildings with low RH, although others found no asso.s:iation. MM and LResp sym _ ptoms identified in of fice buildings with very low RH may be misclassified as SBS because under these conditions the agent and etiology of th_e symptoms may be expla�abl e .
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Associations Betw � en Indoor C02 Concentrations and SBS Symptoms in U.S. Office Buildings
The BASE Study Health Endpoint and Demographic Questionnaire Data
The BASE questionnaire was used to confidentially col lect information from the building occupants, includ ing gender, age, smoking status, the physical environ ment of the occupants' individual work stations, job characteristics, the occupants' perceptions of the work place environment, and their health and well-being. The questionnaire collected data on the following symptoms: irritation of eyes, nose, and throat; chest tightness, difficulty breathing, cough, or wheezing; fa tigue; headache; eyestrain; and dry or itchy skin. To qu,alify as a SBS symptom in the analyses presented here, the occupant must have a reported symptom oc currence of at least 1-3 days per week during the month previous to the study and that the symptom must have "got better" when he/she Was away from work. Information on the BASE questionnaire and the exact health question wording is available from the USEPA BASE Website reference. Two health endpoints used in this study are com bined mucous membrane (CMM) symptoms and com bined lower respiratory (CLResp) symptoms. Occu pants were coded as having a CMM symptom if they reported one or more mucous membrane (MM) symp tom (i.e., eye irritation; stuffy or runny nose or sinus congestion; sore throat). Likewise, they were coded as having a CLResp symptom if they reported having at least one lower respiratory (LResp) symptom (i.e., chest tightness; difficulty breathing; cough; and wheez ing). Although numerous other SBS symptom data were collected in the BASE study, this paper focuses on the MM and LResp symptoms because they are likely to be the most informative with regard to the proposed hypotheses.
Statistical Methods
The associations between MM and LResp SBS symp toms and elevated indoor C02 levels were examined in a number of ways. Crude and multivariate analyses were conducted using both dC02 and dC02MAX as the primary independent variable. Analyses using both continuous and. binary C02 variables were conducted. In addition, multivariate dose-response effects were in vestigated using both C02 metrics.
The multivariate logistic regression (MLR) models were constructed in order to control for potential con founders. Each MLR model contained a SBS symptom as the dependent variable and a C02 metric (dC02 or dC02Max) as at:! independent variable. Adgitional co variates included in the models were age, gender, s ?1 oking status of responde ! lt, presence of carpet in workspace, RH, and thermal exposure, and TMB. As discussed above� MM and LResp symptoms in en vironments with very low RH may be misclassified as SBS. In order to avoid potential biases due to low hu midity the eight buildings with RH less than 20% were excluded from the regression analyses.
The statistical analyses reported in this paper were conducted using SAS 6.12 software (SAS, 1989) using established biostatistical methods (Kleinbaum et al., 1982; Selvin, 1995) . Crude prevalence odds ratios (OR), Wald Maximum Likelihood (WML) statistics, and 95% confidence intervals were calculated using the SAS Logistic procedure. The MLR analyses were conducted using stepwise selection with an entry significance level of 0.5 and a significance level of 0.15 for allowing an independent variable to stay in the model. Models were constructed using both continuous C02 data and using binary variables cut at the median values of the dC02 and dC02MAX distributions (e.g., buildings with C02 concentration below median=O while C02 concentration at or above median=l).
The median dC02 and dC02MAX concentrations were 140 and 350 ppm, and the ranges were 6-418 ppm and 120-716 ppm, respectively. The dC02 and dC02M AX ORs are reported in units per-100 ppm and per-250 ppm, respectively, chosen to scale with the ratio of their median values (i.e., 250/100=350/140). This selection of OR units for C02/SBS symptom associ ations provides a basis of relative comparability be tween the measures of association derived using dC02 and dC02MAX.
In order to assess the possible existence of a dose-re sponse relationship between the C02 metric and SBS symptoms, additional analyses were conducted where the C02 metrics were divided into five categories based upon their distributions across the 41 buildings. A low est group, the occupants of buildings in the bottom 10th percentile of C02 metric levels was used as a reference. The occupants in buildings with top 10th percentile of C02 levels were set as the highest exposure group, and the rest of the population in the study was binned into three groups split between the top and bottom 10th per centiles. For the purpose of calculating the association between the SBS symptoms and C02 level an analysis of covariance approach was taken (Selvin, 1995) : dummy variables were used to represent the four highest C02 bins. Stepwise MLR models were built that forced these four dummy variables into the model and then allowed additional significant covariables to be included (p:s0.15). These regressions were used to assess trends for the associations between SBS symptq _ ms and dC02 or dC02MAX for the four upper COrlevel building _ groups using the building group with the lowest 10tJ1 percentile concentrati � ns as a baseline. A test was conducted to assess multivariate dose response. Additional logistic regressions using a single categorical C02 variable with five levels representing the above-defined binned-C02 groupings were con ducted. These levels were coded using the bin-mean dC02 or dC02Max value for each C02 level. The WML statistic and associated p-value for this categorical vari able was used as a measure-of-fit of the dose-response relationship for the adjusted categorical associations between C02 measures and SBS symptoms (SAS, 1989) .
In order to as, sess the potential for reducing SBS symptoms through improvements in building venti lation and or indoor pollutant source reduction, a value based on the odds ratio was derived. For symp toms with low prevalence (i.e., <5%) the OR is a dose approximation of relative risk (RR), the ratio of the risk of symptoms in the exposed population to the risk in the unexposed population (Jekel et al. , 1996) . The per cent risk reduction (PRD) for SBS symptoms in the ex posed population can be calculated as follows:
In the case of symptoms with prevalence greater than 5% an approximation of the PRD can be made based upon simple comparisons of the differences between the calculated PRD using the OR vs. RR. In the case of prevalence between 5% and 10% and an OR ::5 about 10 the correction is less than -10% PRD. Likewise, in the case of prevalence of 30% and an OR ::5 about 10 the correction is less than -20% PRD.
Results
The average and ranges of a few informative physical and demographic characteristics from the 1994-1996 BASE Study needed for this paper follow are shown in Table l . Further details for many of the characteristics can be found elsewhere (Womble et al., 1996) . All of the buildings had at least some air-conditioned spaces.
The prevalence of operable windows in the buildings was as follows: 60% had 0% operable, 25% had at least 50% operable, and 18% had 100% operable. Some smoking areas were allowed in 39% of the buildings, 3 (7%) buildings had no smoking restrictions, while smoking was observed in 5 (12%) of the buildings where it was prohibited.
C02 Concentrations, Symptom Prevalences, and
Relative Humidity Figure 1 depicts the statistical distribution, and Appen dix 1 tabulates the dC02 and dC02MAX variables for all 41 buildings. Median dC02 and dC02MAX concen trations were 140 and 350 ppm, and the ranges were 6-418 ppm and 120-716 ppm, respectively. In no case was the indoor average or the peak indoor C02 extra ordinarily high, with only one building having abso lute indoor C02 concentrations routinely above 1000_ ppm. In terms of indoor C02 concentrations, and thus, in terms of ventilation rate per occupant these build- ings were consistent with the literature (Seppanen et al., 1999) .
Selected overall SBS symptom prevalences for 1994-1996 BASE buildings are shown in Table 2 RH and the prevalence of the symptoms listed in Table   2 was conducted. This analysis showed that there was no statistically significant association at 95% confi dence level between low RH and the symptoms, al though the Dry Skin and Sinus Congestion were mar ginally significant (p=0.07 and p=0.10, respectively). These marginal associations were enough indication of an RH effect to support the exclusion of the eight low RH buildings (391 individual respondents) from the subsequent analyses. A total of 1,579 respondents from the 33 remaining buildings were included in the analyses. Table 3 presents both crude and adjusted ORs and 95% confidence intervals (CI) using both continuous dC02 data and constructed median-split binary dC02 vari ables. The results significant at the 95% confidence level are discussed here, and all regression results are shown in Table 3 . The ORs for the crude associations between continuous and Sore Throat, Nose/Sinus, and Wheeze ranged from 1.1 to 1.5 per 100 ppm inerease in dC02. After inclusion of age, gender, smoking status of respondent, presence of carpet in workspace, and thermal exposure, and TMB in the multivariate step wise LR models, statistically significant associations were found between 100 ppm dC02 and Sore Throat, Nose/Sinus, Tight Chest, and Wheeze, again with ORs ranging from 1.1 to 1.5. The combined symptom, CMM, was associated with 100 ppm dC02 (OR=l.l). The binary dC02 analyses indicated statistically sig nificant (crude and adjusted) associations with Nose/ Sinus SBS symptoms (adjusted OR=l.5), and the ad justed OR for CMM was 1.3.
Logistic Regression Results
dC02 Analyses
As stated above, this paper focuses on MM and LResp symptoms. However, for completeness we pro vide the following adjusted dC02 results for the other SBS symptoms listed in Ta ble 1. The OR (95% CI) for building related Fatigue or Sleepiness, Headache, Tired of Strained Eyes, and Dry or Itchy Skin were 0.9 (0.8-1.1), 1.0 (0.9-1.2), 1.0 (0.9-1.2), and 1.0 (0.8-1.3), respec tively. These results are typical for the discussed symp toms in all of the analyses presented below. Figure 2 presents the results of the analysis of the trend between dC02 and symptoms, after adjustment for potential confounders, with the data from buildings in the lowest C02 bin serving as the reference. Total sample size for each symptom is also shown (N range from 1404 to 1508). Visually, the plots suggest possible dose-response relationships, but usually with the OR in one binned group deviating from the expected dose response pattern. Based on the WML tests for statisti cally significant trends, the following symptoms or symptom groups have a significant dose response (p <0.05) relationship with dC02: CMM, Sore Throat (p<0.005), Irritated Nose/Sinus, Tight Chest and Wheeze. 1.1 (0.9-1.2)
1.5 (1.2-1.9)* 1.1 (1.0-1.3)
1.1 (0.9-1.6) 1.2 (0.9-1.7) 0.9 (0.6-1.3) 1.0 (0.7-1.2) Ta ble 4 presents both crude and adjusted ORs and 95% Cis using both continuous dC02MAX data (per 250 ppm), and constructed median-split binary dC02MAX variables. The unadjusted and adjusted ORs for the as sociation between continuous dC02MAX and Sore Throat was 2.0 and 2.3 per 250 ppm, respectively (p<0.005). In addition, the CMM (OR=l.3), Nose/Si nus (OR=1.4) and Wheeze (OR=l.9) symptoms were found to be significantly associated in the adjusted, continuous models. The binary dC02MAX analyses in dicated statistically significant adjusted associations with Sore Throat symptoms (OR=2.0, p<0.005), Nose/ Sinus symptoms (OR=l.5), and Wheeze (OR=3.0).
Although not shown, a statistically significant in creasing trend in OR was measured for. all MM symp toms in the DC02MAX analyses. Although the data were noisier between bins than for the dC02 analyses, the within bin confidence intervals were tighter. LResp symptoms for dC02MAX showed no statistically sig nificant dose-response, however marginally significant trends were evident for Tight Chest (p=0.13) and Wheeze (p=0.06).
Covariables in Adjusted Models
Many of the variables used to control for confounding in the multivariate regression models were statistically significant. Most associations were significant at the 95% confidence level, however in some instances the covariables were only significant with p<0.15. The choice of dC02 or dC02MAX did not substantially change the associations between the covariables and SBS symptoms. For the continuous models the associ _ations between covariables_ and the MM and LResp _ symptoms are summarized as follows. Age: OR=1.2 to 1.3 per 10 years above 2o years of age (Cough and Wheeze only). Gender: OR=l.5 to 6.4 (female relative T ble 4 Calcu lated crude and adjusted prevalence odds ratios indicating associations between maximum 1-h average indoor -average �tdo or .wo rkday C02 (dC02 MAX) levels and selected mucous membrane and lower respiratory sick building syndrome symptoms. �he data fol" the se analyses were collected in the 1994-1996 BASE study Chest/breath 1.1 (0.8-1.4) 1.1 (0.9-1.S) 1.2 (0.8-1.7) 1.1 (0.5-2.2) 0.7 (0.4-1.4) 1.1 (0.7-1.7) 2.2 (1.0-5.1)
1.3 (0.9-2.0) 1.8 (0.9-5.2) 1 : 2 (0.5-2.9) 1.2 (0.7-2.1)
Chest tight 1.3 (0.8-2.2) 1.6 (1.0-2.8) Short breath 0.9 (O.S-1.4) 1.6 (0.8-3.0) Cough 1.0 (0.7-1.4) 1.2 (0.8-1.7) Wheeze 1.6 (0.9-2.7)
1.9 (1.1-3.4)
"All associati ons in bold are statistically significant at the 95% confidence level or higher. Values in parentheses are the 95% confidence interval. bCutpoint at median=350 ppm. Table 5 presents adjusted odds ratios for SBS symp toms at the maximum dC02 and dC02MAX values ob served in the 41 BASE buildings. These ORs are based on the same continuoks analyses shown in Tables 3  and 4 . This recasting ,of the analyses puts the SBS sym p tom risks into clear perspective. The implication is that office buildings with average absolute indoor C02 concentrations of roughly 800 ppm (or absolute 1-h maximum mnrentrations of about 1000 ppm) may have about 1.5 to 6.2 times the prevalence of MM and LResp symptoms as compared to buildings with about 400 ppm C02.
The PRD estimates from the maximum dC02 analyses of (low prevalence symptoms) Tight Chest and Wheeze are 80% and 85%, respectively. PRD cannot be used to directly calculate prevalence reduction in the MM symptoms (prevalence is greater than 5%), however using the correction discussed above, a conservative es timate for reduction of sore throat SBS symptoms (prevalence 6.9%) through mitigation is about 70%.
Discussion
Symptom Prevalence
The SBS prevalences observed in the BASE Study build ings (Table 2) , are comparable to those observed in other studies, an important issue when considering the rel evance of the findings of this study. For example, the combined prevalences for MM and LResp symptoms in 12 office buildings (N = 880) of the California Healthy Building Study were 40.3% and 7.5%, respectively (Fisk et al., 1993) . Mendell and Smith (1990) reanalyzed symp tom prevalences reported in six epidimiologic studies. Sample size weighted prevalences for nose, eye, and throat symptoms from three studies with non-humidi fied air-conditioned buildings were 27%, 25%, and 40%, respectively (Total N = 1524). Sample size weighted "tight chest" and "difficulty breathing" symptom prevalences from two of these buildings were about 10%. Bluyssen et al. (1996) present symptoms from 56 European office buildings (N =6537) representing nine countries. Mean prevalences of dry eyes, stuffy nose, runny nose, and irritated throat symptoms, evaluated at the time of questioning, were 26%, 31%, 11 %, and 29%, respectively. The mean chest tightness prevalence was Table 5 Adjusted prevalence odds ratios and 95% confidence in tervals for the risk of mucous membrane and lower respiratory SBS symptoms at the maximum dC02 (418 ppm) and dC02MAX 6.3 (L2-34)
• All associations in bold are statistically significant at the 95% _confidence level or higher. Value� in parentheses are the 95% con-_ fidence interval.
• p::: 0.005 10%. When symptoms were reported retrospectively for the "last month," prevalences were somewhat higher.
Potential for Reduction of Risk
The results of these analyses indicate a clear association between elevated indoor C02 levels and certain MM and LResp SBS symptoms. Analyses were conducted using average and maximum indoor C02, and the find ings were similar in each case. The findings were gener ally evident in the crude regression models, and were strengthened through adjustment for a number of po tential confounders. Although the models using binary C02 variables were less statistically powerful they also showed similar associations. The strongest responses were identified for sore throat and wheezing symptoms. Both the adjusted dC02 and dC02MAX ORs indi cated increase risk of MM and LResp symptoms. Al though the dC02 and dC02MAX variables are not exact ly equivalent in unit values, it appears that the dC02M AX associations with symptoms are slightly stronger. It is unknown whether this is a real difference or merely an artifact, however, one potential explanation is that the dC02MAX metric tracks the peak indoor concen trations of other pollutants and SBS responses may be due to episodic peak concentrations. Further, the larger variance (greater Cis) seen in the dC02MAX analysis re sults may be due to the dC02MAX data being based upon less underlying data than the dC02 (e.g., peak 1-h average vs. 3 workday average).
The odds ratios for the associations of symptoms with the maximum observed difference between indoor and ' outdoor C02 concen,trations may indicate the maximum potential to reduce selected SBS symptoms through large increases in ventilation rates. The maximum values of dC02 and dC02MAX are 418 and 716 ppm, re spectively. Table 5 provides these ORs. Considering only the significant associations, ORs range from 1.7 to 6.2 (with an extreme of 10.2 for dC02MAX/ sore throat). Based upon the PRD calculations from the maximum observed dC02, the maximum potential reductions in symptom prevalences are roughly 70% to 85%.
Epidemiological Interpretation
Bias and Confounding
It is possible that the apparent associations are due to some type of bias. Major sources of bias due to con founding have been accounted for, with gender being the most consistent and strongest confounder. Certainly other undetermined sources of confounding may be at work. Selection bias �ue to the study design is p�ssible.
However the buildings were selected from a probability sample, and the design is cross-sectional. There is no reason to suspect that the BASE Study design differenti-254 ally favors exposed SBS cases, or non-exposed non-SBS cases, as would be necessary for this type of bias. The cross-sectional design, although not very sensitive, should be less subject to selection bias.
Tne analyses discussed in this study controlled for many of the sources of confounding to be expected in the relationship between environmental stresses and SBS in office buildings. However, residual confounding may remain unaccounted for. Potential residual confounding by factors associated with both C02 (as a surrogate for building occupancy and per-person ventilation) and symptoms may include physical characteristics of the buildings such as building age, sealed windows, the type of ventilation system, the type of carpet present, and the type of activities occurring in the buildings. The level of building maintenance and cleaning of buildings has not been accounted for. Personal characteristics not controlled for include atopy, and history of and treat ment for asthma, but these are not likely to be associated with C02 concentrations. Work-related factors such as satisfaction with the environment, job stress, and job sat isfaction may also be unaccounteq contributors to con founding. The BASE Study dataset contains many more variables than were used in these analyses, including work-related factors, atopy, and asthma.
Information bias due to error in classification of SBS cases from non-cases is possible. It is reasonable to think that the BASE questionnaire might encourage individ uals who are dissatisfied with their environment to re port symptoms more strongly than they are actually ex perienced. To fully resolve this question is difficult, however the questionnaire has been refined over several generations of studies. The BASE protocol and quality assurance requirements ensure that the physical meas urements are accurate and sufficiently precise. It may also be possible to assess information bias by using other health endpoint data (i.e., "numbness in hands or wrists") collected in the BASE Study that are not con sidered to be caused by air pollutants.
Dose Response
The analyses of trend explored in this study indicate statistically significant evidence of dose-response re lationships between indoor C02 levels and MM and LResp symptoms. Dose-response is particularly evident for the dC02 analyses, but also for the MM symptoms in the dC02MAX analyses. Not surprisingly, since the data were divided into five subcategories to conduct these analyses, the confidence intervals for the individual bin OR estimates are_quite large.
The dose-response analyses reflect the assumptions of linearity in the regression models. This assumption is not necessarily correct, and fits to nonlinear respons � functions might provide further information on the dose dependence of the SBS symptoms. This was not ex plored in these analyses, in part because the limited sample size of the binned data has limited power for meaningful comparisons of different response func tions. Larger datasets are needed to further interpret the nature of these relationships.
Consistency of Findings
A body of evidence suggests that these findings are con sistent with those of other research. However, few studies have reported the odds ratios or relative risks for these observations. Seppanen et al. (1999) cite only three studies where risk ratios were presented for the associ ation between indoor eo2 levels and health outcome. Two of these studies do not report SBS symptoms (pneu monia and perceived indoor environmental quality). In the third study, Sieber et al. (1998) discuss finding statis tically significant associations between elevated mean afternoon eo2 (buildings with > 1000 ppm vs. :5800 ppm) and symptoms of the lower respiratory tract (on the day of questioning) after adjusting for confounding effects from gender, age, and smoking status. Their cal culated ORs (95% confidence interval) were 2.0 (1.3-3.0) for tight chest, 1.8 (1.1-3.0) for shortness of breath, and 2.4 (1.3-4.4) for both symptoms concurrently. Although a direct comparison between the analyses of Sieber et al. and those presented in this paper is not possible, the strength of associations in the two studies are compar able. Although tight chest symptoms were only (mar ginally) significant in on'o analysis (Table 3 ) and a signifi cant association with shqrt breath was never seen, a sig nificant association with wheezing, also a LResp symptom was evident in all of the analyses.
Four studies were reported in the review by Seppanen et al. (1999) where MM and LResp symptoms prevalence was observed to increase in relation to indoor eo2 con centrations, but the relationship was not quantified with a measure of risk. MM irritation including dry and/ or hoarse throat; stuffy nose; and itching, burning or other wise irritated eyes were observed in three of the studies (Croes et al., 1995; Hill et al., 1992; Sohn et al., 1994) . Fi nally, Bright et al. (1992) included dif ficulty breathing as a component in a satisfaction metric (other components were fatigue, drowsiness, and lack of concentration) found to be correlated with indoor eo2, however the relative influence of the difficulty breathing symptom in the composite metric was not reported.
Biological Considerations
Du e to the nature of these analyses, where eo2 is an in dicator of other undetermined environmental stressors, direct explanations of biological action are not possible.
However, numerous potential sources of airborne con taminants are known to be present in office buildings. As discussed above, these sources include human bioef fluents, and pollutants emitted by building materials, furniture, electronic and office equipment, cleaning and other activities, etc.
A detailed analysis of the plausibility for all SBS-caus ing agents of indoor origin will not be discussed here. For exemplary purposes the plausibility of the effects of per-person ventilation-rate-moderated voe exposures on SBS is explored. Sources of indoor voes have been associated with statistically significant increases in the risk of MM and LResp symptoms in office buildings (Ten Brinke et al., 1998; Apte and Daisey, 1999) . Individ ual voe species identified in office buildings are known to have irritating effects upon human mucosal tissues and the respiratory tract (Ten Brinke et al., 1998) . Mass balance dictates that increases in building ventilation will lead to lower steady-state indoor concentrations of VOes emitted from indoor sources. Thus, the hypo thesis that the observed relationship between per-per son ventilation rates (as traced by de02 and de02MAX) and MM and LResp symptoms is biologically credible.
Conclusions
After adjusting for confounding variables, we found sig nificant associations of mucous membrane and lower respiratory SBS symptoms with increases of dC02 and de02MAX when workday average eo2 levels were al ways below 800 ppm.
ORs for significant associations of symptoms with 100 ppm increases in de02 were 1.1 to 1.5. ORs for signifi cant associations of symptoms with 250 ppm increases in de02MAX were 1.3 to 2.3.
Statistically significant dose-response relationships were found between de02 and the following symp toms: sore throat, irritated nose/sinus, combined mu cous membrane symptoms, tight chest, and wheeze.
Implications: These results suggest that increases in the ventilation rates among typical office buildings will, on average, significantly reduce prevalences of several SBS symptoms, even when these buildings meet the existing ASHRAE ventilation standards for office build ings. The magnitude of the reduction will depend on the magnitude of the increase in ventilation rates. Very large increases in ventilation rates, sufficient to reduce indoor eo2 concentrations to approximately outdoor levels, would be expected to decrease prevalences of selected �ymptoms by 70% to 85%. �are should be taken in im-_ plementing such a ventilation strategy in the case where outdoor RH levels are low, as such a practice may lead to undesira�ly fow indoor RH. It is unde:stood that there is 255 ) no direct causal link between exposure to C02 and SBS symptoms, but rather C02 is approximately correlated with other indoor pollutants that may cause symptoms.
---
